Back 1 new Ph. Eur. reference standard and 15 replacement batches released in February 2024

EDQM Strasbourg, France 01/03/2024
  • Diminuer la taille du texte
  • Augmenter la taille du texte
  • Imprimer la page
  • Imprimer en PDF
1 new Ph. Eur. reference standard and 15 replacement batches released in February 2024

See also:

The European Directorate for the Quality of Medicines & HealthCare (EDQM) announces the release of:

  • 1 new European Pharmacopoeia (Ph. Eur.) reference standards:

Catalogue code

Name

 

Unit quantity

Price

Y0002439

Haloperidol decanoate impurity mixture CRS

1

0.08 mg

79 EUR

 

Additional information:

The standards cannabis flower for system suitability HRS and cannabidiol for cannabis CRS that are described in the newly adopted monograph on Cannabis flower (3028) are now available for users under catalogue code Y0002440 and Y0002422 respectively.

  • 15 replacement batches for Ph. Eur. reference standards:

Catalogue code

Name

Batch

Unit quantity

Price

Y0001795

Amorolfine for system suitability CRS

2

10 mg

79 EUR

F0700000

Furosemide CRS

3

100 mg

79 EUR

Y0001892

Remifentanil hydrochloride CRS - * narc

2

100 mg

79 EUR

Y0001307

Costunolide CRS

3

15 mg

79 EUR

I0725000

Isopropyl hexadecanoate CRS

3

100 mg

79 EUR

Y0001435

Montelukast for peak identification CRS

5

20 mg

79 EUR

P2152000

Pivmecillinam hydrochloride CRS

3

100 mg

79 EUR

G0326012

Gliclazide impurity F CRS

6

70 mg

79 EUR

Y0001270

Timolol for system suitability CRS

4

5.03 mg

79 EUR

Y0001964

Albendazole for system suitability CRS

2

10 mg

79 EUR

F0200000

Fluocinolone acetonide CRS

6

110 mg

79 EUR

Y0001672

Meldonium impurity B CRS

2

25 mg

79 EUR

O0700000

Oxytocin CRS

8

41 mg

90 EUR

Y0001486

Pyridostigmine impurity B CRS

2

15 mg

79 EUR

T1950000

Triamcinolone hexacetonide CRS

4

100 mg

79 EUR

 

  • Distribution quota

Information on distribution quota for Immunoglobulin (anti-A, anti-B antibodies test Negative control) BRP (Y0001689)

Due to premature depletion of stocks of the Immunoglobulin (anti-A, anti-B antibodies test Negative control) BRP (cat. # Y0001689), we wish to inform users that a tight distribution quota has been established.

This BRP will be distributed to plasma-derived therapeutic product manufacturers and Official Medicines Control Laboratories only, with a maximum of 1 unit per month. This quota may be adjusted according to availability.

This exceptional measure will remain in place until the next batch of this BRP is established, which is expected by the end of 2024.

Distribution of the Immunoglobulin for anti-A, anti-B antibodies limit test BRP (cat. # Y0001153) and the Immunoglobulin (anti-A, anti-B antibodies test Positive control) BRP (cat. # Y0001688) is not affected by this measure.

We apologise for any inconvenience caused and thank you for your understanding.

Information on reference standards removed from catalogue

  • Supplement 11.3

Following the implementation of Supplement 11.3, the following standards are officially withdrawn (or replaced) from 1 January 2024.

Y0002166

Donepezil Hydrochloride Monohydrate

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1 July 2024. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1 January 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.

Y0000679

Mepyramine impurity A

Y0001288

Salbutamol sulfate for system suitability (replaced by Salbutamol for peak identification CRS Y0002386)

Y0000030

Salbutamol impurity B           

Y0000071

Salbutamol impurity D

Y0000031

Salbutamol impurity F

Y0000034

Salbutamol impurity G

Y0000032

Salbutamol impurity I

Y0000371

Sestamibi labelling kit (replaced by Sestamibi labelling kit A CRS Y0002420)

Y0000115

Sotalol impurity B

T2200010

Trimethoprim impurity B

Y0000684

Trimethoprim for system suitability (replaced by Trimethoprim for peak identification CRS Y0002392)

 

Information on reference standards with a future removal from catalogue

  • Additional removal from catalogue

Catalogue code

Name

 

I0305000

Insulin (bovine) CRS

This reference standard will be officially withdrawn from sale on 30/06/2024. The reference will remain visible in the catalogue until 31/12/2024.

 

  • Supplement 11.4

Following the implementation of Supplement 11.4, the following standards will be officially withdrawn (or replaced) from 1st April 2024.

S2400004

Suxibuzone impurity B CRS

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1st October 2024. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1st April 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.

T0040000

Temazepam CRS - * psy

Y0000346

Temazepam impurity F CRS

Y0000344

Temazepam impurity C CRS

Y0000345

Temazepam impurity D CRS

Y0000347

Temazepam impurity G CRS

Y0002071

Calcium folinate for system suitability CRS (replaced by calcium folinate for system suitability A CRS)

 

  • Supplement 11.5

Following the implementation of Supplement 11.5, the following standard will be officially withdrawn (or replaced) from 1st July 2024.

C2320000

Clomifene citrate CRS

These standards will nevertheless remain available for sale, subject to sufficient stock, until 1st January 2025. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1st July 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details.

 

Information on change of sales units

  • None

Information on change of amount per unit

  • Flutamide CRS (F0285600) batch 3 contains 55 mg per unit (100 mg previously).
  • Pyridostigmine impurity B CRS (Y0001486) batch 2 contains 15 mg per unit (10 mg previously).
  • Gliclazide impurity F (G0326012) CRS batch 6 contains 70 mg per unit (50 mg previously).
  • Timolol for system suitability (Y0001270) CRS batch 4 contains 5.030 mg per unit (5.045 mg previously).
  • Costunolide (Y0001307) CRS batch 3 contains 15 mg per unit (10 mg previously).
  • Tetryzoline hydrochloride (Y0000460) CRS batch 1.2 contains 15 mg per unit (10 mg previously).

Information on change of price

  • None

Information on change of EDQM storage/shipping conditions

Based on new stability information, storage and shipping conditions will be changed on 15 March 2024 for the following reference standard:

  • Doxorubicin hydrochloride (D2975000) CRS batch 7 is stored at +5°C (previously -20°C) and shipped at ambient temperature (previously on ice at -20°C).

Information on International Chemical Reference Substances (ICRS) and International Standards for Antibiotics (ISA)

ICRS

  • None

ISA

  • None

Content of the European Pharmacopoeia RS catalogue

The EDQM proposes more than 3 100 Ph. Eur. RS including a wide range of highly characterised chemical reference substances (CRS), herbal reference standards (HRS) and biological reference preparations (BRP), as well as reference spectra for the tests and assays to be carried out in accordance with the official methods prescribed in the Ph. Eur.

The Ph. Eur. RS catalogue is updated on a daily basis and gives access not only to all the Ph. Eur. RS, but also to:

  • batch validity statements (BVSs) for each reference standard;
  • Safety Data Sheets and Safety Data Statements for hazardous biologicals;
  • leaflets (downloadable PDFs).

For your convenience, the Ph. Eur. RS catalogue is published daily and can be downloaded in in PDF format and in XML format.

When stocks of a given reference standard are low, the EDQM reserves the right to limit the quantities sold to each user to ensure that as many users as possible will receive at least some of the quantities available. Restrictions on quantities are applied at the time the purchase order is received.

Following a request from many users, the quantities allowed in case of sales restrictions now appear in the online catalogue as well as in the catalogue in XML format.

The EDQM is also responsible for the establishment, preparation, storage and distribution of WHO International Chemical Reference Standards (ICRS) and International Standards for Antibiotics (ISA).

How to place an RS order

If you wish to place an order, you can send your request to the EDQM either:

  • via the WebStore;
  • or by e-mail to [email protected] (in this case, please ensure that your order, on your company letterhead, states both the catalogue code and substance name and is attached to your e-mail).

A video has been prepared to help user ordering through the RS WebStore.

The EDQM helps the users to test some draft texts proposed in Pharmeuropa through Qualified Samples

In some cases, ‘qualified samples’ are made available by the EDQM at the time of publication in Pharmeuropa to allow users to check the changes (e.g. to the related substances test) proposed during the public enquiry and best prepare for the implementation of the monograph.

Where a qualified sample is available, it is described in the briefing note of the Pharmeuropa monograph and may be ordered free of charge by raising a request in the EDQM HelpDesk.

After use, users are kindly requested to share their results with the EDQM.

To place an order via the EDQM HelpDesk, please click on European Pharmacopoeia and choose the category Question about General Chapters and Monographs. Providing us with your full shipping address and the title of the corresponding Ph. Eur. monograph, while stating ‘Qualified sample’ in the subject of the query, will help us to rapidly process your request.

For further information on how to use the EDQM HelpDesk, please see the HelpDesk User Manual.